151 related articles for article (PubMed ID: 18620493)
1. Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection?
Tsoupras AB; Chini M; Tsogas N; Fragopoulou E; Nomikos T; Lioni A; Mangafas N; Demopoulos CA; Antonopoulou S; Lazanas MC
AIDS Res Hum Retroviruses; 2008 Aug; 24(8):1079-86. PubMed ID: 18620493
[TBL] [Abstract][Full Text] [Related]
2. Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen.
Chini M; Tsoupras AB; Mangafas N; Tsogas N; Papakonstantinou VD; Fragopoulou E; Antonopoulou S; Gargalianos P; Demopoulos CA; Lazanas MC
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):766-75. PubMed ID: 22050695
[TBL] [Abstract][Full Text] [Related]
3. Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: ii) study of the abacavir/lamivudine/efavirenz HAART regimen.
Chini M; Tsoupras AB; Mangafas N; Tsogas N; Papakonstantinou VD; Fragopoulou E; Antonopoulou S; Gargalianos P; Demopoulos CA; Lazanas MC
Int J Immunopathol Pharmacol; 2012; 25(1):247-58. PubMed ID: 22507337
[TBL] [Abstract][Full Text] [Related]
4. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.
Verouti SN; Tsoupras AB; Alevizopoulou F; Demopoulos CA; Iatrou C
Int J Artif Organs; 2013 Feb; 36(2):87-96. PubMed ID: 23335378
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells.
Tsoupras AB; Fragopoulou E; Nomikos T; Iatrou C; Antonopoulou S; Demopoulos CA
Mediators Inflamm; 2007; 2007():27683. PubMed ID: 17710109
[TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure.
Detopoulou P; Nomikos T; Fragopoulou E; Antonopoulou S; Kotroyiannis I; Vassiliadou C; Panagiotakos DB; Chrysohoou C; Pitsavos C; Stefanadis C
Clin Biochem; 2009 Jan; 42(1-2):44-9. PubMed ID: 18955040
[TBL] [Abstract][Full Text] [Related]
7. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial.
Gavriil L; Detopoulou M; Petsini F; Antonopoulou S; Fragopoulou E
Br J Nutr; 2019 May; 121(9):982-991. PubMed ID: 30940217
[TBL] [Abstract][Full Text] [Related]
8. Platelet activating factor levels and metabolism in Tangier disease: a case study.
Kolovou V; Papakonstantinou VD; Stamatakis G; Verouti SN; Xanthopoulou MN; Kolovou G; Demopoulos CA
Lipids Health Dis; 2012 Jul; 11():89. PubMed ID: 22769014
[TBL] [Abstract][Full Text] [Related]
9. Baseline and 6-Week follow-up levels of PAF and activity of its metabolic enzymes in patients with heart failure and healthy volunteers--a pilot study.
Detopoulou P; Fragopoulou E; Nomikos T; Antonopoulou S; Kotroyiannis I; Vassiliadou C; Panagiotakos DB; Chrysohoou C; Pitsavos C; Stefanadis C
Angiology; 2013 Oct; 64(7):522-8. PubMed ID: 23000600
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta stimulates platelet-activating factor production in U-937 cells modulating both its biosynthetic and catabolic enzymes.
Vlachogianni IC; Nomikos T; Fragopoulou E; Stamatakis GM; Karantonis HC; Antonopoulou S; Demopoulos CA
Cytokine; 2013 Aug; 63(2):97-104. PubMed ID: 23673285
[TBL] [Abstract][Full Text] [Related]
11. In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.
Tsoupras AB; Chini M; Tsogas N; Lioni A; Tsekes G; Demopoulos CA; Lazanas MC
J Inflamm (Lond); 2011 Jul; 8():17. PubMed ID: 21736752
[TBL] [Abstract][Full Text] [Related]
12. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions.
Vlachogianni IC; Fragopoulou E; Stamatakis GM; Kostakis IK; Antonopoulou S
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):176-83. PubMed ID: 26358846
[TBL] [Abstract][Full Text] [Related]
13. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients.
Tsoupras AB; Chini M; Mangafas N; Tsogas N; Stamatakis G; Tsantila N; Fragopoulou E; Antonopoulou S; Gargalianos P; Demopoulos CA; Lazanas MC
Angiology; 2012 Jul; 63(5):343-52. PubMed ID: 21948973
[TBL] [Abstract][Full Text] [Related]
15. Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells.
Xanthopoulou MN; Asimakopoulos D; Antonopoulou S; Demopoulos CA; Fragopoulou E
Food Chem; 2014 Dec; 165():50-9. PubMed ID: 25038648
[TBL] [Abstract][Full Text] [Related]
16. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
17. Activities of enzymes involved in the metabolism of platelet-activating factor in neural cell cultures during proliferation and differentiation.
Francescangeli E; Lang D; Dreyfus H; Boila A; Freysz L; Goracci G
Neurochem Res; 1997 Oct; 22(10):1299-307. PubMed ID: 9342735
[TBL] [Abstract][Full Text] [Related]
18. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of vitamin supplements on platelet-activating factor and its metabolism in age-related macular degeneration.
Moschos MM; Chatziralli IP; Stamatakis G; Papakonstantinou VD; Demopoulos CA
Cutan Ocul Toxicol; 2014 Sep; 33(3):235-41. PubMed ID: 24147947
[TBL] [Abstract][Full Text] [Related]
20. Characterization of acetyl-CoA: lyso-PAF acetyltransferase of human mesangial cells.
Fragopoulou E; Iatrou C; Demopoulos CA
Mediators Inflamm; 2005 Oct; 2005(5):263-72. PubMed ID: 16258193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
